These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3428478)

  • 41. R- and S-Warfarin inhibition of vitamin K and vitamin K 2,3-epoxide reductase activities in the rat.
    Fasco MJ; Principe LM
    J Biol Chem; 1982 May; 257(9):4894-901. PubMed ID: 7068669
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vitamin K metabolism and vitamin K1 status in human liver samples: a search for inter-individual differences in warfarin sensitivity.
    Thijssen HH; Drittij-Reijnders MJ
    Br J Haematol; 1993 Aug; 84(4):681-5. PubMed ID: 8217828
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Solubilization and characterization of vitamin K epoxide reductase from normal and warfarin-resistant rat liver microsomes.
    Hildebrandt EF; Preusch PC; Patterson JL; Suttie JW
    Arch Biochem Biophys; 1984 Feb; 228(2):480-92. PubMed ID: 6696443
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship of dithiothreitol-dependent microsomal vitamin K quinone and vitamin K epoxide reductases inhibition of epoxide reduction by vitamin K quinone.
    Preusch PC; Suttie JW
    Biochim Biophys Acta; 1984 Mar; 798(1):141-3. PubMed ID: 6704420
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Purification and properties of a factor from rat liver cytosol which stimulates vitamin K epoxide reductase.
    Siegfried CM
    Arch Biochem Biophys; 1983 May; 223(1):129-39. PubMed ID: 6859852
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Warfarin resistance in a Chicago strain of rats.
    Misenheimer TM; Suttie JW
    Biochem Pharmacol; 1990 Nov; 40(9):2079-84. PubMed ID: 2242035
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Warfarin resistance. Vitamin K epoxide reductase of Scottish resistance genes is not irreversibly blocked by warfarin.
    Thijssen HH
    Biochem Pharmacol; 1987 Sep; 36(17):2753-7. PubMed ID: 3632704
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microsomal lipoamide reductase provides vitamin K epoxide reductase with reducing equivalents.
    Thijssen HH; Janssen YP; Vervoort LT
    Biochem J; 1994 Jan; 297 ( Pt 2)(Pt 2):277-80. PubMed ID: 8297331
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The relationship between inhibition of vitamin K1 2,3-epoxide reductase and reduction of clotting factor activity with warfarin.
    Choonara IA; Malia RG; Haynes BP; Hay CR; Cholerton S; Breckenridge AM; Preston FE; Park BK
    Br J Clin Pharmacol; 1988 Jan; 25(1):1-7. PubMed ID: 3370190
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structure and function of vitamin K epoxide reductase.
    Tie JK; Stafford DW
    Vitam Horm; 2008; 78():103-30. PubMed ID: 18374192
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vitamin K 2,3-epoxide reductase: the basis for stereoselectivity of 4-hydroxycoumarin anticoagulant activity.
    Thijssen HH; Baars LG; Vervoort-Peters HT
    Br J Pharmacol; 1988 Nov; 95(3):675-82. PubMed ID: 3207986
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of S-warfarin administration on vitamin K 2,3-epoxide reductase activity in liver, kidney and testis of the rat.
    Thijssen HH; Janssen CA; Drittij-Reijnders MJ
    Biochem Pharmacol; 1986 Oct; 35(19):3277-82. PubMed ID: 3768021
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Purified vitamin K epoxide reductase alone is sufficient for conversion of vitamin K epoxide to vitamin K and vitamin K to vitamin KH2.
    Chu PH; Huang TY; Williams J; Stafford DW
    Proc Natl Acad Sci U S A; 2006 Dec; 103(51):19308-13. PubMed ID: 17164330
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stereospecificity of vitamin K-epoxide reductase.
    Preusch PC; Suttie JW
    J Biol Chem; 1983 Jan; 258(2):714-6. PubMed ID: 6822505
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanism of coumarin action: sensitivity of vitamin K metabolizing enzymes of normal and warfarin-resistant rat liver.
    Hildebrandt EF; Suttie JW
    Biochemistry; 1982 May; 21(10):2406-11. PubMed ID: 6807339
    [TBL] [Abstract][Full Text] [Related]  

  • 56. No strict coupling of vitamin K1 (2-methyl-3-phytyl-1,4-naphthoquinone)-dependent carboxylation and vitamin K1 epoxidation in detergent-solubilized microsomal fractions from rat liver.
    Wallin R
    Biochem J; 1979 Mar; 178(3):513-9. PubMed ID: 454361
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Normal and warfarin-resistant rat hepatocyte metabolism of vitamin K 2,3-epoxide: evidence for multiple pathways of hydroxyvitamin K formation.
    Trivedi LS; Rhee M; Galivan JH; Fasco MJ
    Arch Biochem Biophys; 1988 Jul; 264(1):67-73. PubMed ID: 3395132
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Studies of the vitamin K-dependent carboxylase and vitamin K epoxide reductase in rat liver.
    Suttie JW; Preusch PC
    Haemostasis; 1986; 16(3-4):193-215. PubMed ID: 3530899
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vitamin K1 hydroquinone formation catalyzed by DT-diaphorase.
    Fasco MJ; Principe LM
    Biochem Biophys Res Commun; 1982 Jan; 104(1):187-92. PubMed ID: 6803779
    [No Abstract]   [Full Text] [Related]  

  • 60. The relationship between the vitamin K cycle inhibition and the plasma anticoagulant response at steady-state S-warfarin conditions in the rat.
    Mosterd JJ; Thijssen HH
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1081-5. PubMed ID: 1545379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.